Novonix (ASX:NVX) won a US$100m grant from the US Department of Energy
Today was a good morning for investors in Novonix (ASX:NVX). Its shares rose as much as 22% after winning a…
An Appendix 4C release can do miracles for stocks, just look at Nexion (ASX:NNG)
Tuesday was the deadline for ASX companies to lodge their Appendix 4C (or quarterly report) with the stock market for…
ASX gold stocks are back in vogue and these 4 stocks are benefitting
ASX gold stocks dominated the winners’ list on Monday morning for two good reasons. First, because in a time of…
These 2 ASX200 consumer stocks are doing fine amidst the cost of living crisis
There were 2 ASX200 consumer stocks that were winners on Friday morning. The companies were Ampol (ASX:ALD) and Super Retail…
Here’s why Zip shares had a 10% dead cat bounce on Tuesday
Zip shares had a 10% dead cat bounce on Tuesday. For those who are unaware, a dead cat bounce is…
Treasury Wine Estates (ASX:TWE): Here’s why there’s hope it can rebuild its business in China
Treasury Wine Estates (ASX:TWE) finally has realistic hope that it can rebuild its once-storied business in China. And the stock…
Weebit Nano and DB HiTek: The ASX’s most advanced semiconductor stock and top tier fab are partners
Meet the latest commercial marriage among ASX semiconductor stocks – Weebit Nano and DB HiTek. Weebit Nano (ASX:WBT) is the…
Hub24 (ASX:HUB): There’s a good reason why it is up 50% this year
Hub24 (ASX:HUB) is a growth stock that has somehow managed to perform in the difficult market environment. Glancing at today’s trading…
More Qantas executive changes this morning…and potentially more at its eagerly anticipated AGM?
More Qantas executive changes were announced this morning. And there could be more to come as the company seeks to…
Show Me the Money! Besra Gold & Black Rock Mining are seeing it this morning
ASX resources stocks Besra Gold (ASX:BEZ) and Black Rock Mining (ASX:BKT) were winners this morning after investors liked the news…
These 2 ASX biotechs reported strong clinical data from Phase 2 trials
Clinical data is the best way for investors in ASX biotechs to tell whether or not it has a chance…
Will war in Israel impact stocks? Is it 1973 all over again?
Will war in Israel impact stocks? So far it hasn’t impacted the ASX significantly, although it has hit the Israel…
Dimerix (ASX:DXB) signs a A$230m deal!
Dimerix (ASX:DXB) achieved one of the most important milestones a biotech must achieve before commercialising a drug or medical device.…
Noxopharm (ASX:NOX) is up over 100% after getting Orphan Drug Designation – but is it that big a deal?
Noxopharm (ASX:NOX) is the ASX’s biggest winner, climbing as much as 166% higher than it closed yesterday. And it is all…
Here’s why this pot stock gained a stunning 40% this morning
As of 10.30am this morning, the biggest gaining ASX stock with news was pot stock ECS Botanics (ASX:ECS), all thanks…